Results

Total Results: 207 records

Showing results for "vascular".

161. Update on the Methods of the U.S. Preventive Services Task Force: Insufficient Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/inevidup.pdf
     September 01, 2009 - Recommendations for Adults: Heart and Vascular Diseases: Screening for Miettinen OS.

162. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DQgVKNYn6gFtXLfwthuRBU
     June 12, 2020 - for improving visual acuity.15 The most common treatment for wet AMD is intravitreal injections of vascular

163. Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/G9P7o8jDh4J3NnAk6y-SYL
     December 01, 2011 - Prostatectomy was associated with perioperative death (about 0.5%) and cardio- vascular events (0.6% … Medicare database study, perioperative rates of serious cardiovascular events were 3% and rates of vascular … studies (n � 1243 [63] and 11 010 [59]), rates of cardiovascular events were 0.6% and 3% and rates of vascular … Diabetes and cardio- vascular disease during androgen deprivation therapy: observational study of vet

164. Screening for Syphilis Infection in Nonpregnant Adults: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/VhSwc46MPwjDPNsgVrVm-B
     June 07, 2016 - ranges from 85% to 99% and may be reduced in persons who have a preexist- ing condition (ie, collagen vascular

165. Archived: Evidence Summary: Screening for Dyslipidemia in Younger Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-dyslipidemia/statin-use-in-adults-preventive-medication-november-2016
     November 13, 2016 - Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, et al; Prevention of Renal and Vascular

166. C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/khUSqr94jqWPErt9ZRnQ95
     October 01, 2009 - Is C-reactive protein specific for vascular disease in women? Ann Intern Med. 2002;136:529-33. … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

167. Ad-Br2Otj67Fendhhkltpa (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/aD-Br2oTJ67FeNdHHkLtPA
     for pregnant women Kidney disease Chronic obstructive airways disease Heart disease, stroke, vascular

168. Archived: Decision Analysis: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/decision-analysis-for-aspirin/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual … for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular

169. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - stroke did not differ between aspirin and placebo, 3 , 57  in healthy patients, 45  in patients with vascular … Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses

170. Archived: High Blood Cholesterol and Other Lipid Abnormalities: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-cholesterol-other-lipid-abnormalities-screening-1996
     January 01, 1996 - These benefits are now well established for persons with preexisting atherosclerotic vascular disease … Hypertriglycerid[a]emia and vascular risk. Lancet . 1993;342:781–787. [ PubMed ] 46.

171. T6Tquunynv3Twm65Bfash2 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/T6Tquunynv3tWM65BFash2
     October 01, 2015 - the FDA issued a safety communication indicat- ing a nonsignificant increase in major adverse cardio- vascular … in 2014 (35), a meta-analysis of 18 studies (n = 9072) showed no significant increase in all cardio- vascular

172. 6Jfgjyjsbmc48Mj2Uksahb (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6jFgJYJSbMc48mj2uKsAhB
     October 01, 2014 - USPSTF recommends offering or referring adults who are overweight or obese and have additional cardio- vascular

173. Recommendation: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication
     April 26, 2022 - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual

174. Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for CVD Prevention in Adults Without Known CVD Risk Factors: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/HMSNGkJatRuN5VoVWfbuFL
     March 01, 2022 - Other Related USPSTF Recommendations The USPSTF has several recommendations for promoting cardio- vascular

175. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TsBkyewVoFpC7htRmzWJa
     September 03, 2019 - treatment trials of women with noninva- sive and early stage breast cancer, such as fractures and cardio- vascular … Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics

176. Archived: Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
     October 07, 2011 - Medicare database study, perioperative rates of serious cardiovascular events were 3% and rates of vascular … studies ( n =1243 63 and 11,010 59 ), rates of cardiovascular events were 0.6% and 3% and rates of vascular

177. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/LPaUxRbrTshfsYVVTzenEQ
     April 26, 2022 - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of

178. Archived: Tobacco Use Prevention: Counseling, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-prevention-counseling-1996
     January 01, 1996 - leading risk factor for myocardial infarction and coronary artery, cerebrovascular, and peripheral vascular

179. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/uM5P-6XpsqVfEC2axGnZaD
     November 16, 2020 - However, when analyses focused on major cardiovascular adverse events (combined outcome of cardio- vascular … cardiovascular adverse events (RR, 1.03 [95% CI, 0.71-1.50]; 27 trials; n = 10 402),82 or major cardio- vascular

180. Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
     April 01, 2013 - Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics … Year-by-year analysis of cardio- vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE